Sysmex Corporation (TYO:6869)
Japan
· Delayed Price · Currency is JPY | Market Cap | 918.88B |
| Revenue (ttm) | 502.95B |
| Net Income (ttm) | 44.75B |
| Shares Out | 623.18M |
| EPS (ttm) | 71.77 |
| PE Ratio | 20.54 |
| Forward PE | 17.63 |
| Dividend | 36.00 (2.45%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 4,915,200 |
| Average Volume | 5,047,560 |
| Open | 1,500.00 |
| Previous Close | 1,472.00 |
| Day's Range | 1,457.50 - 1,502.00 |
| 52-Week Range | 1,268.00 - 2,934.00 |
| Beta | 0.68 |
| RSI | 54.19 |
| Earnings Date | Feb 12, 2026 |
About Sysmex
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte co... [Read more]
Financial Performance
In fiscal year 2025, Sysmex's revenue was 508.64 billion, an increase of 10.21% compared to the previous year's 461.51 billion. Earnings were 53.67 billion, an increase of 8.12%.
Financial StatementsNews
Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors
Invesco International Small-Mid Company Fund outperformed most in the real estate and consumer staples sectors due to stock selection. The fund's underweight in real estate also added to relative retu...
Sysmex Corporation (SSMXY) Q1 2026 Earnings Call Transcript
Sysmex Corporation (OTCPK:SSMXY) Q1 2026 Earnings Conference Call August 6, 2025 3:00 AM ET Company Participants Kaoru Asano - President & Representative Director Kensuke Iizuka - Corporate Participan...